Skip to main content
. 2012 Mar 28;303(2):F259–F265. doi: 10.1152/ajprenal.00689.2011

Fig. 6.

Fig. 6.

A: adding the PKC activator phorbol-12-myristate-13-acetate (PMA; 2 × 10−7 M) to the CNT perfusate enhanced CTGF (n = 6; *P < 0.05; **P < 0.01; ***P < 0.001, with vs. without PMA). B: adding tempol to the CNT lumen blocked the stimulatory effect of PMA on CTGF (n = 6; **P < 0.01; ***P < 0.001, with vs. without tempol).